Anebulo Pharmaceuticals, Inc. (ANEB)
NASDAQ: ANEB · Real-Time Price · USD
1.050
+0.175 (20.00%)
Jan 30, 2026, 2:45 PM EST - Market open
Anebulo Pharmaceuticals Market Cap
Anebulo Pharmaceuticals has a market cap or net worth of $43.14 million as of January 30, 2026. Its market cap has increased by 4.26% in one year.
Market Cap
43.14M
Enterprise Value
25.59M
1-Year Change
4.26%
Ranking
Category
Stock Price
$1.05
Market Cap Chart
Since the IPO on May 7, 2021, Anebulo Pharmaceuticals's market cap has decreased from $162.86M to $43.14M, a decrease of -73.51%. That is a compound annual growth rate of -24.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 35.95M | -13.37% |
| Dec 31, 2025 | 41.50M | -4.76% |
| Dec 31, 2024 | 43.57M | -29.77% |
| Dec 29, 2023 | 62.03M | -0.15% |
| Dec 30, 2022 | 62.13M | -56.73% |
| Dec 29, 2021 | 143.57M | -11.85% |
| May 7, 2021 | 162.86M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Generation Bio Co. | 37.86M |
| Serina Therapeutics | 37.75M |
| Rein Therapeutics | 37.59M |
| OnKure Therapeutics | 36.99M |
| Tvardi Therapeutics | 36.59M |
| NextCure | 36.56M |
| Celularity | 36.54M |
| RenovoRx | 35.18M |